Technology
The U.S. Food and Drug Administration (FDA) approved the Conformable Gore TAG Thoracic Endoprosthesis for endovascular repair of acute and chronic Type B dissections of the descending thoracic aorta. The Conformable Gore TAG Thoracic Endoprosthesis is designed for multiple thoracic etiologies, and is the only device to receive FDA indications for aneurysm, trauma and dissection. Previously, the only approved treatment options were medical management or open surgical repair.
October 01, 2013
News
Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Complete SE (self-expanding) vascular stent for use in the lower extremities –– specifically, the superficial femoral artery (SFA) and proximal popliteal artery (PPA), which carry blood through the upper legs.
October 01, 2013
Technology
Clinicians face the challenge of effectively imaging larger patients. Recognizing this trend, Esaote’s new eHD Technology improves every element of the imaging chain and increases ultrasound’s ability to image with more clarity at greater depth.
October 01, 2013Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific symposium in late October.
October 01, 2013News
Whole-body magnetic resonance imaging (MRI) may serve as a valuable noninvasive tool for assessing the risk of heart attack and stroke in diabetic patients, according to a new clinical study published online in the journal Radiology.
October 01, 2013
News
Sunshine Heart Inc. has launched a website dedicated to providing information to patients suffering from moderate to severe heart failure to learn about its C-Pulse U.S. pivotal trial, COUNTER HF(TM).
October 01, 2013Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
Medtronic Inc. announced clinical trial results showing that heart failure patients treated with its AdaptivCRT feature experienced a nearly 50 percent reduction in atrial fibrillation (AF) risk. Pioneered by Medtronic, the AdaptivCRT technology is a feature on certain cardiac resynchronization therapy-defibrillators (CRT-Ds) that continually adjusts therapy to a patient's natural heart rhythms and minimizes the amount of unnecessary right ventricular (RV) pacing. The results were presented as a late breaking clinical trial at the Heart Failure Society of America's 17th Annual Scientific Meeting.
September 30, 2013
News
At RSNA 2013, GE Healthcare will highlight the latest hardware and advanced applications for its Discovery IGS angiography platform. These updates are geared towards addressing the challenges of healthcare providers, support clinical decision making and helping clinicians in refining overall patient care.
September 30, 2013
News
Critical Diagnostics announced the clinical study, “Head-to-head comparison of two myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 vs. Galectin-3,” recently published online in Journal of the American College of Cardiology (JACC) comparing the company’s cardiac biomarker ST2 to Galectin-3 (Gal-3), a biomarker from BG Medicine, found ST2 to be superior.
September 30, 2013Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
Ascendian Healthcare Consulting announced a new service line to assist clients with ensuring the confidentiality, integrity and availability of patient data — the medical imaging client’s privacy, data security and patient safety consulting services.
September 30, 2013News
A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow trials of different sizes and durations to be compared easily. This measurement also helps to illustrate the high costs associated with delays.
September 30, 2013
Feature | Dave Fornell
The U.S. Senate passed legislation Sept. 26 to reauthorize, extend and improve operations of the Federal Helium Reserve in Texas, which will guarantee a stable supply of the gas used for cooling magnetic resonance imaging (MRI) systems.
September 30, 2013Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
CardioLogical Solutions announced that it has been issued two additional patents for its family of aortic embolic protection devices designed to prevent stroke and other ischemic complications. The new patents include its first issued patent for its Emboline CAP technology, the only aortic embolic protection solution to offer comprehensive arterial protection, as well as a further patent for its broad embolic deflector intellectual property portfolio. CardioLogical Solutions now has four issued patents for aortic embolic protection.
September 30, 2013
Feature | Nuclear Imaging | E. Gordon DePuey, M.D., director of nuclear medicine, St. Luke’s-Roosevelt Hospital, N.Y
The highest levels of radiation dose in medical imaging are reported in nuclear medicine and pressure is growing for lower dose.
September 27, 2013
Feature | Dave Fornell
A large number of emergency room visits are for chest pain evaluation, and many hospitals are adopting CT angiography as a primary test to quickly rule-out coronary disease.
September 27, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now